<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title><![CDATA[EC21 Product Catalogs - cas28319 77 9]]></title>
<link><![CDATA[https://www.ec21.com/ec-market/cas28319 77 9.html]]></link><item>
<title><![CDATA[Alpha GPC, Choline Alfoscerate,Cas 28319-77-9]]></title><link><![CDATA[https://wuhufomanbiopharma.en.ec21.com/Alpha_GPC_Choline_Alfoscerate_Cas--9093504_9093506.html]]></link><description><![CDATA[Alpha GPC (L-alpha-glycerophosphocholine)
cas#28319-77-9,
molecular formula:C8H20NO6P，
Molecular mass:257.22
purity:99%, 85%, 50%
Competitive Advantage:
1. High purity
2. Low impurity
3. Low residu]]></description><pubDate><![CDATA[20240912]]></pubDate></item>
<item>
<title><![CDATA[None Hygroscopicity Alpha GPC CAS 28319-77-9]]></title><link><![CDATA[https://jenniferlau.en.ec21.com/None_Hygroscopicity_Alpha_GPC_CAS--9132480_9724245.html]]></link><description><![CDATA[CAS No: 28319-77-9 
Formula: C8H20NO6P 
Mol. Mass: 257.22 
Appearance: off-white to white crystalline powder or colorless sticky liquid. 
Assay: 50% Granular powder. 85% Transparent liquid and 99% wh]]></description><pubDate><![CDATA[20151023]]></pubDate></item>
<item>
<title><![CDATA[Alpha Gpc,  CHOLINE ALFOSCERATE]]></title><link><![CDATA[https://fomanbiopharma.en.ec21.com/Alpha_Gpc_CHOLINE_ALFOSCERATE--9099841_9099842.html]]></link><description><![CDATA[We are key producer of Alpha-GPC(cas no.: 28319-77-9) in China, 
Output for GPC: 100mts/year. (as Drug for patients suffering from dementia such as Alzheimer&amp;rsquo;s disease and cerebovascular condit]]></description><pubDate><![CDATA[20140805]]></pubDate></item>

</channel>
</rss>